VON DER IDEE ZUR INNOVATION

acib hat ein Netzwerk aus zahlreichen KMUs und großen Industriepartnern aus unterschiedlichsten Bereichen der industriellen Biotechnologie aufgebaut. Viele dieser Firmen sind Teil des COMET Konsortiums, das – zeitlich und finanziell begrenzt – nur eine von vielen, auch alternativen Kooperationsmodellen darstellt.

Ein attraktives Angebot für Stakeholder aus der Industrie ist das Akademische Partner-Netzwerk, das Organisationen aus der Industrie den Zugang zu F&E-Aktivitäten eines individuell zugeschnittenen Forschungskompetenz-Portfolios von derzeit mehr als 53 wissenschaftlichen Partnern ermöglicht.

acib ALS FORSCHUNGS-HUB

acib’s Position als zielgerichteter Forschungs-Hub für industrielle Biotechnologie wird weiter ausgebaut. Durch die Bündelung aller Partner und Netzwerke in ein vertragliches acib Partner-Netzwerk ist das acib in der Lage, die Welten aus Wissenschaft und Industrie zu verbinden, um Innovation und wissenschaftliches Know-how zu ermöglichen. Somit ist das acib ein One-stop-shop und idealer Partner für Open Innovation.



AKTUELLE ANGEBOTE – FORSCHUNGSMARKTPLATZ

acib bietet Ihnen neue Technologien, Expertise und Projektkonzepte. Bleiben Sie auf dem Laufenden durch unsere aktuellen Angebote, indem Sie sich zu unserem Newsletter anmelden. Für weitere Informationen kontaktieren Sie bitte Martin Trinker.

 

59 / PROJECT OFFER

Recombinant Protein Production


24.08.2020

view offer

58 / PROJECT OFFER

Protein Engineering


24.08.2020

view offer

57 / PROJECT OFFER

Biotechnological synthesis of pure ingredients of natural essential oils


20.05.2020

view offer

56 / PROJECT OFFER

Discovery platform for antiviral agents to SARS-CoV-2 and other high risk pathogens in a BSL-3+ laboratory


19.05.2020

view offer

55 / PROJECT OFFER

endSARS


15.04.2020

view offer

54 / PROJECT OFFER

ProFabSARS


15.04.2020

view offer

53 / PROJECT OFFER

SARS-CoV-2 monoclonal antibodies


08.04.2020

view offer

52 / PROJECT OFFER

SARS-CoV-2 glycoprotein expression


08.04.2020

view offer

51 / PROJECT OFFER

KINaCoV-2


08.04.2020

view offer

50 / PROJECT OFFER

CURES – SARS-CoV-2


01.04.2020

view offer

49 / PROJECT OFFER


MUTATRACER – SARS-CoV-2


01.04.2020

view offer

48 / PROJECT OFFER

HOPE – SARS-CoV-2


01.04.2020

view offer

47 / TECHNOLOGY OFFER

Enzymatic treatment of tumble dryer residues


11.02.2020

view offer

46 / TECHNOLOGY OFFER

Enzymatic baby diapers recycling


11.02.2020

view offer

45 / PROJECT OFFER

Biocatalytic valorisation of fatty acids


14.01.2020

view offer

44 / PROJECT OFFER

Contact-based antimicrobial (nano)materials


14.01.2020

view offer

43 / PROJECT OFFER

Rainbow Cell Technologies


3.04.2019

view offer

42 / PROJECT OFFER

Fighting Biofilms


12.02.2019

view offer

41 / PROJECT OFFER

CO2-Recycling and Biopolymers


09.01.2019

view offer

40 / PROJECT OFFER

(Micro)plastic degradation


09.01.2019

view offer

39 / PROJECT OFFER

Bioleaching / Bioremediation


09.01.2019

view offer

38 / PROJECT OFFER

Enzyme discovery and development for polymer processing


13.12.2017

view offer

37 / PROJECT OFFER

3D Phase Contrast Microscopy for Flow Cytometry


13.12.2017

view offer

36 / PROJECT OFFER

Improving the immunogenicity of vaccines


13.12.2017

view offer

35 / TECHNOLOGY OFFER

Up-regulation of protein expression through use of RNA polymerase binding aptamers (RAPS)


21.11.2017

view offer

34 / PROJECT OFFER

Making nanoparticles more stable for biological environments


20.11.2017

view offer

33 / SERVICE OFFER

Smart library approaches employing the BioXPTM 3200 platform


13.11.2017

view offer

32 / PROJECT OFFER

Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry


13.06.2017

view offer

31 / PROJECT OFFER
Project on Antibacterial Antibiotic Discovery and Development


13.06.2017

view offer

30 / CO-DEVELOPMENT OFFER
Inhibition of gene expression from „foreign DNA“


13.06.2017

view offer

29 / PROJECT OFFER
BioF&F – Biotechnological production of Flavor & Fragrance compounds


30.03.2017

view offer

28 / PROJECT OFFER
BOSS – Biotechnological Optimizations by Selection Systems


29.03.2017

view offer

27 / PROJECT OFFER
Biocatalytic methylation and demethylation of phenol derivatives


24.03.2017

view offer

26 / PROJECT OFFER
Lactic Acid Production

view offer

25 / PROJECT OFFER
Biorefinery Solutions
10.03.2017

view offer

24 / PROJECT OFFER
Photo-BioPolymers


10.03.2017

view offer

23 / CO-DEVELOPMENT OFFER
GISS – Gastro Intestinal Simulation System


view offer

22 / TECHNOLOGY OFFER
Compact and optimized metabolic pathway design in yeasts


16.02.2017

view offer

21 / SERVICE OFFER
Assembly of multi-part DNA constructs


26.01.2017

view offer

20 / SERVICE OFFER
Metabolomics


19.01.2017

view offer

19 / SERVICE OFFER
13-C labeled metabolite extract


19.01.2017

view offer

18 / PROJECT OFFER
Towards the next generation of industrial bioethanol production


19.01.2017

view offer

17 / PROJECT OFFER
Project offer: Towards the Next Generation of Lignocellulose-Based Industrial Biomanufacturing


19.01.2017

view offer

16 / PROJECT OFFER
Biotechnological synthesis of natural insect repellents


17.01.2017

view offer

15 / PROJECT OFFER
Continuous biocatalysis using liquid membrane technology


13.12.2016

view offer

14 / SERVICE OFFER
Bioinformatics


13.12.2016

view offer

13 / COMPETENCE OFFER
Biocatalytic Synthesis and Enzyme Technology


18.11.2016

view offer

12 / PROJECT OFFER
Enzymatic Alkene Cleavage


28.10.2016

view offer

11 / PROJECT OFFER
Biotechnological preparation of chitin and chitosan from shrimp shell waste


25.10.2016

view offer

10 / TECHNOLOGY OFFER
3D Enzyme Search


view offer

9 / PROJECT OFFER
Synthesis of bio-based resveratrol analogues


23.08.2016

view offer

8 / PROJECT OFFER
Combinatorial pathway assembly for Green Chemistry


26.07.2016

view offer

7 / SERVICE OFFER
Directed modification of proteins using unnatural amino acids


26.07.2016

view offer

6 / CO-DEVELOPMENT OFFER
Drug Resistance


18.07.2016

view offer

5 / TECHNOLOGY OFFER
Novel Hydroxynitrile Lyases


05.07.2017

view offer

4 / PROJECT OFFER
Antibacterial Antibiotic Discovery and Development – AntiBac


20.06.2016

view offer

3 / PROJECT OFFER
Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry – BacTech


1.06.2016

view offer

2 / TECHNOLOGY OFFER
Biocatalytic Friedel-Crafts Acylations


25.05.2016

view offer

1 / TECHNOLOGY OFFER
Nanomembranes


11.02.2016

view offer

  • „acib provides excellent research opportunities and advantages, enabling companies to keep pace with the rapid scientific progress.“

    Dr. Henry Müller / CEO Biotenzz

  • „As a pretty young company in the field of biolife-science we appreciate the close cooperation with the absolute experts of acib.“

    Peter Pucher / Head of R&D BDI – BioLife Science

  • „This is the perfect match: research focus to the company´s interest and professional acib partners to collaborate combined with the acib co-funding and administrational support creating the attractive research programme base.“

    Dr. Terhi Puranen / R&D Manager Roal Oy

  • „The collaboration with acib and its constituting body of experts in biotechnology in the framework of a funded R&D competence centre enables us to engage in high-risk potentially high-reward research. We greatly appreciate this opportunity.“

    Dr. Patrick Lorenz / Head of Molecular Biology AB Enzymes

  • „acib is the foundation of our collaboration strategy in Austria.  The projects we undertake within the framework in both Vienna/Tulln and Graz are essential to our innovation strategy.  The quality and continuity of the programs are first rate while the overall context and connectivity that one experiences in parallel add a great deal to the experience.“

    Michael Burnet / Managing Director Synovo

  • „The current cooperation with acib provides an essential and valuable contribution to create new possible value propositions for our products. Thanks for a job well done.“

    Dr. Kurt Eyer / Technical Manager 3M

  • „acib facilitates in a highly professional and efficient manner the collaboration of people from two different worlds, academia and business. Knowing the different mindsets from both sides, acib is a valuable partner in helping to translate the needs and visions of both company and academic partners into a successful joint R&D cooperation.“

    Gerald Ruppert / IP Manager Viscose Faser

  • „We are pleased with the long-lasting collaboration with acib. The open and creative atmosphere and the in general excellent results obtained have over the years contributed to the successful implementation of several industrial process in the production of chemical intermediates at DSM.“

    Dr. Martin Schürmann / Principal Scientist DSM

  • „acib stands out due to the huge pool of multidisciplinary expertise and capabilities available for its industrial partners across the entire field of industrial biotechnology.“

    Dr. Thomas Purkarthofer / Head of Business Development Validogen (formerly VTU Technology)

  • „The current cooperation with acib provides an essential and valuable contribution to improve our existing manufacturing process. The theoretical and practical knowledge provided by acib are key parameters that will bring our joint project to success.“

    Dr. Matthias Müllner / Head of Manufacturing Themis Bioscience

  • „The close and trusting collaboration with acib’s academic partners is a constant source of new and valuable stimulus for the development of innovative metabolic pathways and novel reactor designs for optimal performance of the functionalization of alkanes.“

    Bastian Grund / Project Manager Evonik

  • „Our research and development progress would have been impossible without the collaboration with acib. acib complements our expertise to create a world class laboratory that can execute experiments at a high level. And, when we go to share results, acib’s stellar reputation ensure others have confidence in our data.“

    Edward Eveleth / Chairman HocusLocus

  • „Results generated within acib were implemented into our product development program. We appreciate the solution-oriented research focus.“

    Dr. Nora Temme / KWS Saat

  • „Our acib partners … are doing a thorough work. They pursue the project with diligence and a good sense for focusing on the important issues to be solved. It is a pleasure to collaborate with such a competent team and see continuous progress in achieving the project’s goals.“

    Dr. Judith Wahrheit / Contract Research Biocrates

  • „With the highly engaged acib team the ambitious goals to develop a set of technologies for continuous processing of complex and sensitive molecules could be achieved. Together we could overcome serious challenges and set the base for implementation of some technologies at development/pilot scale and finally also into commercial processes.“

    Dr. Martin Purtscher / Senior Expert Takeda

  • „acib’s broad expertise in biocatalysis provides a valuable contribution to our research activities. We greatly appreciate the open and fruitful collaboration with acib’s research team, that improves our knowledge and shortens the development period of our ambitious projects.“

    Dr. Jürgen Kuballa / CEO GALAB

  • „The acib collaboration provides an important contribution to Sandoz’s new technology evaluation & development programs.“

    Dr. Sascha Keller / Head of Downstream Process Development Sandoz

  • „The collaboration with acib enables us to access state-of-the-art technologies in the field of industrial biotechnology in general and above all in recombinant protein expression. The entire acib project team is dedicated and driven in their ambitions to achieve the project goals. The research performed by acib is excellent and complementary to our own research and greatly appreciated at BIOMIN.“

    Dr. Lukas Sturmberger / Project Leader Biomin

  • „We are working with acib since 2012. The results are exceeding our expectations and thus increase our competitiveness in the international biotechnology-market. We value the high competence and expertise of acib scientists, as well as the open and constructive discussions marked by trust and leading to pioneering innovations.“

    Otto Kanzler / CEO Chorus

  • „Our collaboration with acib has so far proven to be very productive and has resulted in a number of exciting technical applications. The scientific team members are highly qualified and really motivated to pursue their objectives.“

    Dr. Christa Tauer / Head of Bio OpU Process Development Shire

  • „While having grown to a large organization, acib still provides a highly professional and responsive collaborative research environment capable of quickly reacting to specific project needs.“

    Dr. Peter Pöchlauer / Patheon Austria GmbH & Co KG

  • „We are working with acib successfully since 2010. Our long running collaboration with acib is built on trust and a genuine interest in each other’s progress. The collaboration has been very fruitful in both directions and continues to do so due to its strong communication, versatility and adaptability.“

    Dr. Daniel Koch / Head of Strain Development Jungbaunzlauer Austria AG

  • „We run a research project with acib to create a new and innovative route to an existing active pharmaceutical ingredient (API). acib investigated on critical step in the synthesis. They brought in great experience, a very systematic approach and – most importantly – a tremendous drive to get the project done. acib offers excellent research capabilities in all relevant fields. We are already preparing a new project with acib.“

    Dr. Kai Donsbach / CTO, Global Head R&D PharmaZell

  • „The acib collaboration enables rapid and straight-forward research on current requirements of the Roombiotic product pipeline. I personally recommend acib to biotech start-ups as powerful and reliable partner in challenging research projects.“

    Dr. Daniel Treffer / CEO Roombiotic

  • „In all phases of the project we had a very fruitful and open minded communication and the team was always helpful and dedicated to make it a success. Now the 3rd project in a row is being planned and Novartis will benefit from all the knowledge and very good outcome implemented and use it for process optimization and developmental purposes.“

    Ernst Neuhauser / Lead DS Operational Mgmt. Novartis

  • „We have had a great collaboration with our colleagues at acib and we have learned a lot.“

    Dr. Ann Lövgren / Principal Scientist GE Healthcare

  • „The wide spectrum of acib competence and skills in techniques and methods of acib experts is a unique basis for the realization of our product visions at the crossroads between minerals and biotechnology.“

    Gernot Tauterer / Research Director IPUS

  • „acib is a very important R&D partner for Clariant Group Biotechnology in the field of academic cooperation and was chosen because of its specific expertise in Clariant’s fields of interest and current activities. acib provides research expertise which is at the forefront of experimental R&D state of the art, enabling up-to-date research work. acib has broad expertise in various fields of industrial biotechnology (strategic fit to industry needs).“

    Dr. Georg Schirrmacher / Scientific Coordinator Clariant